Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 11 studies | 24% ± 7% | |
| fibroblast | 9 studies | 26% ± 9% | |
| endothelial cell | 9 studies | 24% ± 10% | |
| connective tissue cell | 5 studies | 37% ± 17% | |
| abnormal cell | 4 studies | 20% ± 2% | |
| myofibroblast cell | 4 studies | 27% ± 7% | |
| endothelial cell of artery | 3 studies | 17% ± 2% | |
| epithelial cell | 3 studies | 41% ± 18% | |
| macrophage | 3 studies | 23% ± 2% |
Insufficient scRNA-seq data for expression of PLOD1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 100% | 10067.93 | 1803 / 1809 | 100% | 270.86 | 471 / 472 |
| lung | 100% | 6491.77 | 578 / 578 | 99% | 131.22 | 1147 / 1155 |
| liver | 100% | 6338.15 | 226 / 226 | 99% | 126.67 | 403 / 406 |
| uterus | 100% | 8566.88 | 170 / 170 | 99% | 159.13 | 455 / 459 |
| prostate | 100% | 5304.45 | 244 / 245 | 99% | 95.00 | 499 / 502 |
| breast | 100% | 5993.30 | 459 / 459 | 99% | 132.10 | 1106 / 1118 |
| stomach | 100% | 4145.64 | 359 / 359 | 99% | 88.35 | 282 / 286 |
| intestine | 100% | 5339.05 | 965 / 966 | 98% | 89.08 | 519 / 527 |
| ovary | 100% | 7329.69 | 180 / 180 | 98% | 92.88 | 423 / 430 |
| pancreas | 99% | 3061.04 | 326 / 328 | 99% | 113.97 | 176 / 178 |
| bladder | 100% | 6062.29 | 21 / 21 | 98% | 112.26 | 494 / 504 |
| esophagus | 100% | 5181.63 | 1440 / 1445 | 98% | 97.67 | 179 / 183 |
| brain | 98% | 2583.60 | 2588 / 2642 | 98% | 82.39 | 691 / 705 |
| thymus | 100% | 5366.40 | 653 / 653 | 94% | 84.18 | 570 / 605 |
| kidney | 100% | 5783.71 | 89 / 89 | 92% | 138.91 | 833 / 901 |
| adrenal gland | 100% | 4867.75 | 258 / 258 | 92% | 73.17 | 212 / 230 |
| adipose | 100% | 6813.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 143.27 | 80 / 80 |
| spleen | 100% | 4515.29 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 103.45 | 45 / 45 |
| heart | 100% | 6043.00 | 859 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 6567.74 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 2994.93 | 798 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 4628.30 | 908 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 51.05 | 28 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008544 | Biological process | epidermis development |
| GO_0017185 | Biological process | peptidyl-lysine hydroxylation |
| GO_0001666 | Biological process | response to hypoxia |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_1902494 | Cellular component | catalytic complex |
| GO_0030867 | Cellular component | rough endoplasmic reticulum membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0033823 | Molecular function | procollagen glucosyltransferase activity |
| GO_0005506 | Molecular function | iron ion binding |
| GO_0008475 | Molecular function | procollagen-lysine 5-dioxygenase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0031418 | Molecular function | L-ascorbic acid binding |
| Gene name | PLOD1 |
| Protein name | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1) |
| Synonyms | LLH PLOD |
| Description | FUNCTION: Part of a complex composed of PLOD1, P3H3 and P3H4 that catalyzes hydroxylation of lysine residues in collagen alpha chains and is required for normal assembly and cross-linkling of collagen fibrils (By similarity). Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens . These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links (Probable). . |
| Accessions | ENST00000449038.5 Q5JXB8 Q02809 Q5JXB7 ENST00000196061.5 [Q02809-1] ENST00000429000.6 |